{"id":7465,"date":"2022-01-03T17:26:03","date_gmt":"2022-01-03T09:26:03","guid":{"rendered":"https:\/\/ttic.nhri.edu.tw\/?p=7465"},"modified":"2022-01-03T17:26:03","modified_gmt":"2022-01-03T09:26:03","slug":"2022-01-03","status":"publish","type":"post","link":"https:\/\/ttic.nhri.edu.tw\/en\/2022-01-03\/","title":{"rendered":"Technology Available for Industry-Academia Collaboration or Technology Licensing. \u201cAn Aurora kinase inhibitor for precision targeting of MYC-amplified cancers\u201d (2022\/01\/03)"},"content":{"rendered":"

1. Title:<\/strong>
\nNHRI technology, \u201cAn Aurora kinase inhibitor for precision targeting of MYC-amplified cancers\u201d (abbreviated as \u201cThe Technology\u201d) available for industry-academia collaboration or technology licensing.<\/p>\n

2. Description:<\/strong>
\nAmplification or overexpression of MYC oncoproteins, master regulator of cancers, are observed in over 28% common cancer types. The Technology is a novel aurora kinase inhibitor which was selected based on its potency to reduce levels of MYC oncoproteins with better pharmacokinetic properties compared to the competitor. In addition to small cell lung cancer (SCLC), The Technology inhibits tumor growth and causes tumor regression in various animal models, such as neurofibroblastoma, liver cancer, pancreatic cancer, etc.
\n<\/strong><\/p>\n

3. Potential collaboration partner qualifications:<\/strong>
\n(1) be incorporated and approved by law and does not have any record of misconduct or conviction for any offense
\n(2) better to have related experience and skills for developing The Technology
\n(3) better to have experience of international collaboration and clinical trial
\n(4) be willing to provide long-term investment<\/p>\n

4. Registration\uff1a<\/strong>
\nPlease contact to Mrs. Wan-Ping Hsieh (Address: Technology Transfer and Incubation Center, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan, Tel: +886-37-206166#35798, E-mail: wanping@nhri.org.tw) or Mrs. Wen-Chuan Hsieh (Address: Technology Transfer and Incubation Center, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan, Tel: +886-37-206166#33209, E-mail: wenchuan@nhri.org.tw).<\/p>\n

5. Other:<\/strong>
\n(1) If The Technology has been exclusively licensed, this announcement will automatically invalid.
\n(2) NHRI retains the right to modify and terminate this announcement.
\n(3) For detailed status of The Technology, please contact to the case officer.<\/p>\n

Attachments:<\/strong>
\nI: Announcement<\/a>
\nII: Technology Transfer Vendor Qualification Form<\/a>
\nIII: Industry-Academia Collaboration Proposal<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

1. Title: NHRI technology, \u201cAn Aurora kinase inhibitor for precision targeting of MYC-amplified cancers\u201d (abbreviated as \u201cThe Technology\u201d) available for industry-academia collaboration or technology licensing. 2. Description: Amplification or overexpression of MYC oncoproteins, master regulator of cancers, are observed in over 28% common cancer types. The Technology is a novel aurora kinase inhibitor which was …<\/p>\n

Technology Available for Industry-Academia Collaboration or Technology Licensing. \u201cAn Aurora kinase inhibitor for precision targeting of MYC-amplified cancers\u201d (2022\/01\/03)<\/span> Read More »<\/a><\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[135,147,144],"tags":[],"table_tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/7465"}],"collection":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/comments?post=7465"}],"version-history":[{"count":1,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/7465\/revisions"}],"predecessor-version":[{"id":7473,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/7465\/revisions\/7473"}],"wp:attachment":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/media?parent=7465"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/categories?post=7465"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/tags?post=7465"},{"taxonomy":"table_tags","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/table_tags?post=7465"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}